Literature DB >> 7683656

Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells.

X Zhan1, X Hu, R Friesel, T Maciag.   

Abstract

The importance of growth factor-mediated immediate-early cellular events to the cell cycle has influenced the development and identity of oncogenes and tumor suppressor genes as well as the concept that growth factors commit mammalian cells to enter a biochemical program that ultimately yields DNA synthesis. However, the mid and late events involved in the regulation of growth factor-induced signal transduction remain largely unknown. In this report we demonstrate that BALB/c 3T3 cells require continuous exposure to fibroblast growth factor (FGF)-1 for a minimum of 12 h to achieve near maximal DNA synthesis. This correlates with the continuous internalization of radiolabeled FGF-1 into the cytosol and nucleus of BALB/c 3T3 cells and the maintenance of a low level of FGF receptors on the cell surface during the entire G1 phase of the cell cycle. Further analysis demonstrates the maintenance of a continuous series of differential FGF-1-induced tyrosine phosphorylation events including the phosphorylation of phospholipase C-gamma as well as novel FGF receptor polypeptide substrates, p60, p85, p90, and p130 throughout the G1 phase of the BALB/c 3T3 cell cycle. The tyrosine phosphorylation events are biphasic during the 12-h period after the administration of FGF-1, and the second phase is characterized by hyper-tyrosine phosphorylation of p60, p85, and p130. Interestingly, NIH 3T3 cells which overexpress the FGF receptor-1 polypeptide demonstrate exaggerated tyrosine phosphorylation of p60 and p85 but not p90 and exhibit growth factor-independent cell proliferation. These results suggest that the initiation of DNA synthesis in BALB/c 3T3 cells by FGF-1 is regulated by a complex biochemical program that involves the continuous tyrosine phosphorylation of known and novel polypeptides throughout the G0 to G1 transition period of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683656

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain.

Authors:  M K Webster; D J Donoghue
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression.

Authors:  A M Bennett; S F Hausdorff; A M O'Reilly; R M Freeman; B G Neel
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

3.  Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex.

Authors:  G E Plopper; H P McNamee; L E Dike; K Bojanowski; D E Ingber
Journal:  Mol Biol Cell       Date:  1995-10       Impact factor: 4.138

4.  Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization.

Authors:  A Wiedłocha; P O Falnes; A Rapak; R Muñoz; O Klingenberg; S Olsnes
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

5.  Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts.

Authors:  C Vaziri; D V Faller
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Basic fibroblast growth factor support of human embryonic stem cell self-renewal.

Authors:  Mark E Levenstein; Tenneille E Ludwig; Ren-He Xu; Rachel A Llanas; Kaitlyn VanDenHeuvel-Kramer; Daisy Manning; James A Thomson
Journal:  Stem Cells       Date:  2005-11-10       Impact factor: 6.277

7.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

8.  Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen.

Authors:  Luke P Brewster; Cicely Washington; Eric M Brey; Andrew Gassman; Anu Subramanian; Jen Calceterra; William Wolf; Connie L Hall; William H Velander; Wilson H Burgess; Howard P Greisler
Journal:  Biomaterials       Date:  2007-10-22       Impact factor: 12.479

9.  Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.

Authors:  K Sandvig; M Ryd; O Garred; E Schweda; P K Holm; B van Deurs
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.